1057 related articles for article (PubMed ID: 15935238)
41. The impact of unrecognized bipolar disorders among patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) program: a 6-year retrospective analysis.
McCombs JS; Ahn J; Tencer T; Shi L
J Affect Disord; 2007 Jan; 97(1-3):171-9. PubMed ID: 16860396
[TBL] [Abstract][Full Text] [Related]
42. Compliance with maintenance treatment in bipolar disorder.
Keck PE; McElroy SL; Strakowski SM; Bourne ML; West SA
Psychopharmacol Bull; 1997; 33(1):87-91. PubMed ID: 9133756
[TBL] [Abstract][Full Text] [Related]
43. Management of bipolar disorder.
Griswold KS; Pessar LF
Am Fam Physician; 2000 Sep; 62(6):1343-53, 1357-8. PubMed ID: 11011863
[TBL] [Abstract][Full Text] [Related]
44. A medication algorithm for treatment of bipolar rapid cycling?
Calabrese JR; Woyshville MJ
J Clin Psychiatry; 1995; 56 Suppl 3():11-8. PubMed ID: 7883737
[TBL] [Abstract][Full Text] [Related]
45. Anticonvulsants in bipolar disorder.
Singh V; Muzina DJ; Calabrese JR
Psychiatr Clin North Am; 2005 Jun; 28(2):301-23. PubMed ID: 15826734
[TBL] [Abstract][Full Text] [Related]
46. A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder.
Bridle C; Palmer S; Bagnall AM; Darba J; Duffy S; Sculpher M; Riemsma R
Health Technol Assess; 2004 May; 8(19):iii-iv, 1-187. PubMed ID: 15147609
[TBL] [Abstract][Full Text] [Related]
47. Depression, health-related quality of life, and medical cost outcomes of receiving recommended levels of antidepressant treatment.
Revicki DA; Simon GE; Chan K; Katon W; Heiligenstein J
J Fam Pract; 1998 Dec; 47(6):446-52. PubMed ID: 9866670
[TBL] [Abstract][Full Text] [Related]
48. A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder.
Calabrese JR; Shelton MD; Rapport DJ; Youngstrom EA; Jackson K; Bilali S; Ganocy SJ; Findling RL
Am J Psychiatry; 2005 Nov; 162(11):2152-61. PubMed ID: 16263857
[TBL] [Abstract][Full Text] [Related]
49. Carbamazepine and valproate in the maintenance treatment of bipolar disorder.
Keck PE; McElroy SL
J Clin Psychiatry; 2002; 63 Suppl 10():13-7. PubMed ID: 12392348
[TBL] [Abstract][Full Text] [Related]
50. Rapid titration of mood stabilizers predicts remission from mixed or pure mania in bipolar patients.
Goldberg JF; Garno JL; Leon AC; Kocsis JH; Portera L
J Clin Psychiatry; 1998 Apr; 59(4):151-8. PubMed ID: 9590664
[TBL] [Abstract][Full Text] [Related]
51. Combination lithium and divalproex sodium in pediatric bipolarity.
Findling RL; McNamara NK; Gracious BL; Youngstrom EA; Stansbrey RJ; Reed MD; Demeter CA; Branicky LA; Fisher KE; Calabrese JR
J Am Acad Child Adolesc Psychiatry; 2003 Aug; 42(8):895-901. PubMed ID: 12874490
[TBL] [Abstract][Full Text] [Related]
52. Cost analysis of divalproex sodium extended-release compared to valproic acid in the treatment of bipolar disorder.
Schumock GT; Walton SM; Gupta SR; Cramer JA
Curr Med Res Opin; 2007 Aug; 23(8):1997-2004. PubMed ID: 17637202
[TBL] [Abstract][Full Text] [Related]
53. The impact of unrecognized bipolar disorders for patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) program.
Shi L; Thiebaud P; McCombs JS
J Affect Disord; 2004 Nov; 82(3):373-83. PubMed ID: 15555688
[TBL] [Abstract][Full Text] [Related]
54. Comparison of two anticonvulsants in a randomized, single-blind treatment of hypomanic symptoms in patients with bipolar disorder.
Suppes T; Kelly DI; Hynan LS; Snow DE; Sureddi S; Foster B; Curley E
Aust N Z J Psychiatry; 2007 May; 41(5):397-402. PubMed ID: 17464731
[TBL] [Abstract][Full Text] [Related]
55. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.
Macritchie KA; Geddes JR; Scott J; Haslam DR; Goodwin GM
Cochrane Database Syst Rev; 2001; (3):CD003196. PubMed ID: 11687047
[TBL] [Abstract][Full Text] [Related]
56. Cost-effectiveness of quetiapine with lithium or divalproex for maintenance treatment of bipolar I disorder.
Woodward TC; Tafesse E; Quon P; Kim J; Lazarus A
J Med Econ; 2009; 12(4):259-68. PubMed ID: 19769548
[TBL] [Abstract][Full Text] [Related]
57. [Effectiveness of lithium in the prophylaxis of affective disorders].
Ezquiaga E; García-López A; Nieves P; Rodríguez-Salvanés F
Actas Esp Psiquiatr; 2000; 28(3):156-60. PubMed ID: 11000697
[TBL] [Abstract][Full Text] [Related]
58. An open-label trial of divalproex in children and adolescents with bipolar disorder.
Wagner KD; Weller EB; Carlson GA; Sachs G; Biederman J; Frazier JA; Wozniak P; Tracy K; Weller RA; Bowden C
J Am Acad Child Adolesc Psychiatry; 2002 Oct; 41(10):1224-30. PubMed ID: 12364844
[TBL] [Abstract][Full Text] [Related]
59. Plasma GABA predicts acute response to divalproex in mania.
Petty F; Rush AJ; Davis JM; Calabrese JR; Kimmel SE; Kramer GL; Small JG; Miller MJ; Swann AE; Orsulak PJ; Blake ME; Bowden CL
Biol Psychiatry; 1996 Feb; 39(4):278-84. PubMed ID: 8645774
[TBL] [Abstract][Full Text] [Related]
60. Treatment of agitation and aggression in bipolar mania: efficacy of quetiapine.
Buckley PF; Paulsson B; Brecher M
J Affect Disord; 2007; 100 Suppl 1():S33-43. PubMed ID: 17376537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
